✦ LIBER ✦
The emerging questionable benefit of sorafenib as a neo-adjuvant in HCC patients treated with Y-90 radioembolization pending liver transplantation
✍ Scribed by Shouval, Daniel
- Book ID
- 122124787
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 341 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.